Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

M2062

Greiner CELLSTAR® 384 well plates

flat bottom clear wells (with micro-clear bottom), sterile

Synonym(s):

384 multiwell plates, 384 well microplates, 384 well microtiter plates, 384 well plates

Sign Into View Organizational & Contract Pricing

Select a Size

40 EA
$495.90

$495.90

List Price$522.00Save 5%

In StockDetails

All Photos(1)

Select a Size

Change View
40 EA
$495.90

About This Item

UNSPSC Code:
41122107
NACRES:
NB.22
material:
black polystyrene
flat bottom clear wells (with micro-clear bottom)
maximum volume:
131 μL
size:
384 wells
working volume:
110 μL
sterility:
sterile
binding type:
Tissue Culture (TC)-treated surface
feature:
lid: no

$495.90

List Price$522.00Save 5%

In StockDetails

material

black polystyrene
flat bottom clear wells (with micro-clear bottom)

sterility

sterile

feature

lid: no

packaging

case of 40

manufacturer/tradename

Greiner 781092

maximum volume

131 μL

size

384 wells

working volume

110 μL

binding type

Tissue Culture (TC)-treated surface

Looking for similar products? Visit Product Comparison Guide

General description

CELLSTAR® 384 flat bottom microplate,with an optimal working volume of 15-110 μL; maximum well capacity of 131 μL. Growth area: 10 mm(2)

Other Notes

384 flat well microtiter plate, without lid, rounded square well design, alphanumeric well coding; length: 127.76 +/- 0.15 mm; width: 85.48 +/- 0.15 mm; curvature: approx.150 μm.

Suitability

Black plates minimize background fluorescence. μClear film improves Luminescence; Fluorescence; Cell monitoring; Transmission; and Imaging by reducing background, cross-talk and autofluorescence. Suitable for cell work.

Legal Information

CELLSTAR is a registered trademark of Greiner Bio-One GmbH

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Ruslana Bryk et al.
PLoS pathogens, 16(6), e1008567-e1008567 (2020-06-24)
Efforts at host-directed therapy of tuberculosis have produced little control of the disease in experimental animals to date. This is not surprising, given that few specific host targets have been validated, and reciprocally, many of the compounds tested potentially impact

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service